HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Screening for vaccinia virus egress inhibitors: separation of IMV, IEV, and EEV.

Abstract
Concerns about the possible use of variola virus as a biological weapon as well as the need for therapeutics for the treatment or prevention of naturally acquired poxvirus infections or vaccination complications have led to the search for small molecule inhibitors of poxvirus replication. One unique and attractive target for antiviral development is viral egress. Part of understanding the mechanism of action of viral egress inhibitors involves determining which virion form is being made. This can be accomplished through buoyant density centrifugation.
AuthorsChelsea M Byrd, Dennis E Hruby
JournalMethods in molecular biology (Clifton, N.J.) (Methods Mol Biol) Vol. 890 Pg. 113-21 ( 2012) ISSN: 1940-6029 [Electronic] United States
PMID22688763 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Benzamides
  • Isoindoles
  • Viral Proteins
  • tecovirimat
Topics
  • Animals
  • Antiviral Agents (pharmacology)
  • Benzamides (pharmacology)
  • Blotting, Western
  • Cell Line
  • Centrifugation, Density Gradient
  • Drug Evaluation, Preclinical (methods)
  • Isoindoles (pharmacology)
  • Rabbits
  • Vaccinia virus (drug effects, isolation & purification, physiology)
  • Viral Proteins (metabolism)
  • Virion (drug effects)
  • Virus Cultivation
  • Virus Release (drug effects)
  • Virus Replication (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: